
SUNY Empire Innovation Professor in Biomedical Engineering
Department of Biomedical Engineering
Jacobs School of Medicine & Biomedical Sciences
Cardiopulmonary physiology; Cardiovascular Disease; Metabolism; Molecular and Cellular Biology; Molecular Basis of Disease; Research Lab; Signal Transduction; Vascular Medicine
Dr. Alevriadou received her BS in Chemical Engineering from the Aristotle University, Thessaloniki, Greece, in 1986 and her PhD in Chemical Engineering (Bioengineering & Biosciences Institute) from Rice University, Houston, TX in 1992. Following postdoctoral training in the Department of Molecular & Experimental Medicine at Scripps Research Institute, La Jolla, CA, she joined the BME Department at Johns Hopkins University, Baltimore, MD, as Assistant Professor. In 2003, she joined the BME Center (BME Department, since 2008) and Davis Heart & Lung Research Institute of The Ohio State University as Associate Professor of BME and Internal Medicine, Cardiovascular Medicine. In 2019, she joined the University at Buffalo - The State University of New York (SUNY-Buffalo) as Empire Innovation Professor in BME. Her research on vascular endothelial mechanobiology, intracellular signaling, metabolism, mitochondrial function, and extracellular vesicles, is/has been supported by the National Institutes of Health (NIH) and the American Heart Association (AHA). Dr. Alevriadou is a member of the AHA, the Biomedical Engineering Society (BMES) (1994-present; elected member on the Board of Directors, 2014-2017; elevated to BMES Fellow, 2024-present), the North American Vascular Biology Organization (NAVBO), the Society for Redox Biology & Medicine (SfRBM), and the American Physiological Society (APS). She regularly reviews for federal/local funding agencies (NIH, NSF, AHA) and biomedical and cardiovascular journals. She serves on the Editorial Board of the American Journal of Physiology-Cell Physiology (2002-2019 and 2022-present; Associate Editor, 2019-2021), NAVBO Alert (Contributing Editor, 2022-present), Physiological Reports (2023-present), and Nature-Scientific Reports (2023-present).